Status:
COMPLETED
Dexamethasone for Migraine - Dose Comparison
Lead Sponsor:
Montefiore Medical Center
Conditions:
Migraine
Eligibility:
All Genders
18+ years
Phase:
PHASE4
Brief Summary
Dexamethasone is an evidence-based treatment of acute migraine. This is a randomized comparison of two different doses of dexamethasone for acute migraine. All patients will also be treated with meto...
Detailed Description
Investigational medications. Medications in each study arm are as follows: A. Metoclopramide 10mg IV drip over 15 minutes (for acute treatment)+ dexamethasone 4 mg IV B. Metoclopramide 10mg IV drip o...
Eligibility Criteria
Inclusion
- Moderate or severe migraine
Exclusion
- Medication contra-indication
- Concern for secondary cause of headache
Key Trial Info
Start Date :
December 22 2019
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
December 31 2022
Estimated Enrollment :
209 Patients enrolled
Trial Details
Trial ID
NCT04112823
Start Date
December 22 2019
End Date
December 31 2022
Last Update
March 20 2024
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Montefiore Medical Center
The Bronx, New York, United States, 10467